Special Issue "Recent Advances in Precision Nanomedicine for Cancer"
Deadline for manuscript submissions: closed (31 December 2019).
Interests: drug delivery; nanocarriers; targeted therapy; tumor targeting; tumor vascular targeting; translation therapy; neuroblastoma
Interests: drug delivery; nanocarriers; targeted therapy; tumor microenvironment; macrophages modulation in cancer; 3D-based tumor models; neuroblastoma
Cancer is a leading cause of death worldwide, accounting for about 9.6 million deaths in 2018. The percentage of mortality, mainly due to the lack of a timely diagnosis or to chemotherapy-driven side effects, remains challenging today. Nanoparticle-based precision medicine represents a very attractive tool, as it able to shape the prevention, diagnosis, and therapy of oncological diseases based on the characteristics of an individual or of a limited group of patients. This Special Issue aims to provide a forum for the dissemination of the latest information on new approaches and methods for the prevention, early detection, and treatment of cancer, based on precision nanomedicine.
Dr. Fabio Pastorino
Dr. Chiara Brignole
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Precision medicine
- Anti-cancer therapy
- Theragnostic strategy
- Targeted anti-cancer therapy